RA0270

antibody from Oursmab

Targeting: ST3GAL1 SIAT4A, SIATFL, ST3GalA.1, ST3O

Western blot (Supportive data in Antibodypedia)

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0270

Provider

Oursmab

Product name

Ecromeximab (Biosimilar Reference Antibody) (GD3 ganglioside)

Antibody type

Monoclonal

Description

Ecromeximab is a human-mouse chimeric IgG1 monoclonal antibody specifically developed as a targeted immunotherapy for cancer. It is engineered to recognize and bind with high affinity to the ganglioside GD3, a specific carbohydrate antigen found on the surface of tumor cells. By leveraging the IgG1 framework, the antibody is designed to engage the human immune system effectively, primarily through mechanisms such as antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC), to eliminate GD3-expressing malignant cells.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg-500,10 mg,25 mg,50 mg,305 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Ecromeximab (Biosimilar Reference Antibody) (GD3 ganglioside)-RA0270-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.